Exane Derivatives’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | $1.6M | Sell |
43,067
-2,859
| -6% | -$107K | 0.92% | 21 |
|
2022
Q1 | $2.03M | Sell |
45,926
-3,459
| -7% | -$153K | 0.57% | 33 |
|
2021
Q4 | $2.1M | Sell |
49,385
-47,037
| -49% | -$2M | 0.51% | 36 |
|
2021
Q3 | $4.18M | Sell |
96,422
-3,695
| -4% | -$160K | 1% | 13 |
|
2021
Q2 | $4.31M | Buy |
100,117
+7,755
| +8% | +$334K | 0.98% | 16 |
|
2021
Q1 | $3.57M | Sell |
92,362
-16,414
| -15% | -$634K | 1.02% | 18 |
|
2020
Q4 | $3.91M | Buy |
108,776
+11,024
| +11% | +$396K | 1.15% | 16 |
|
2020
Q3 | $3.74M | Sell |
97,752
-19,354
| -17% | -$740K | 1.08% | 19 |
|
2020
Q2 | $4.11M | Sell |
117,106
-1,628
| -1% | -$57.2K | 1.1% | 20 |
|
2020
Q1 | $3.87M | Buy |
118,734
+40,954
| +53% | +$1.34M | 1.08% | 20 |
|
2019
Q4 | $3.31M | Buy |
77,780
+35,416
| +84% | +$1.51M | 0.61% | 56 |
|
2019
Q3 | $1.72M | Sell |
42,364
-1,598
| -4% | -$65K | 0.31% | 71 |
|
2019
Q2 | $1.89M | Buy |
43,962
+9,479
| +27% | +$407K | 0.33% | 67 |
|
2019
Q1 | $1.32M | Buy |
34,483
+33,319
| +2,862% | +$1.28M | 0.26% | 83 |
|
2018
Q4 | $41.1K | Buy |
1,164
+1,163
| +116,300% | +$41.1K | 0.01% | 344 |
|
2018
Q3 | $39 | Sell |
1
-406
| -100% | -$15.8K | ﹤0.01% | 610 |
|
2018
Q2 | $13.3K | Sell |
407
-1,802
| -82% | -$58.7K | ﹤0.01% | 416 |
|
2018
Q1 | $59K | Sell |
2,209
-534
| -19% | -$14.3K | 0.01% | 324 |
|
2017
Q4 | $68.1K | Buy |
2,743
+2,720
| +11,826% | +$67.5K | 0.01% | 290 |
|
2017
Q3 | $671 | Sell |
23
-127
| -85% | -$3.71K | ﹤0.01% | 425 |
|
2017
Q2 | $4.16K | Sell |
150
-1,538
| -91% | -$42.6K | ﹤0.01% | 399 |
|
2017
Q1 | $42K | Sell |
1,688
-2,112
| -56% | -$52.5K | 0.01% | 256 |
|
2016
Q4 | $82.2K | Buy |
+3,800
| New | +$82.2K | 0.02% | 234 |
|
2015
Q4 | – | Sell |
-2,523
| Closed | -$41.4K | – | 482 |
|
2015
Q3 | $41.4K | Buy |
+2,523
| New | +$41.4K | 0.01% | 245 |
|